Unravel Data Named a Cool Vendor by Gartner in Performance Analysis; Analytics and Containers
The News Follows Unravel’s Introduction of New Artificial Intelligence for IT Operations (AIOps) Capabilities for Automated Performance Tuning of Big Data Applications
PALO ALTO, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Unravel Data, the application performance management (APM) platform designed for big data applications, today announced it has been named a 2018 Cool Vendor by leading research and advisory firm Gartner in the report titled, “Cool Vendors in Performance Analysis; Analytics and Containers.”
Gartner conducts its Cool Vendor research annually. Gartner's Cool Vendor research is designed to highlight interesting, new and innovative vendors, products and services.
For this report, Gartner identified five companies that are leading the market with innovative approaches that I&O leaders can use to address challenges presented by containerization, cloud and microservices.
According to Gartner, “I&O leaders focused on IT operations transformation should: Prepare for their IT environment’s future state and monitoring needs by implementing container- and microservices-ready monitoring tools; Evaluate the vendors in this research by comparing their offerings and ability to deliver insight with those of your current monitoring portfolio; Improve visibility into DevOps and developer teams’ environments by embedding monitoring technologies like those examined in this research early in the development cycle.”
Unravel is the industry’s only APM platform designed for big data. Enterprises across financial, telecom, healthcare, technology and other industries leverage Unravel to operationalize their big data stack and improve reliability of applications and productivity of big data teams while reducing cost of ownership.
Unravel was founded in 2014 and so far in 2018 alone has supported more than 10,000 big data nodes and more than 50 million big data applications at Fortune 1000 companies, such as Kaiser Permanente, Leidos, Autodesk and Microsoft. With the market maturation of how big data investments are being monetized and with cloud migration requirements driving the need to support multi-cloud and hybrid workloads, Unravel delivers innovative AIOps capabilities, broad systems support, and interoperability to drive major efficiency gains and competitive agility for enterprises.
“Unravel Data was founded off the back of first-hand experience with the frustration of manually troubleshooting performance problems in big data stacks,” commented Kunal Agarwal, CEO of Unravel Data. “Today, we’re helping enterprises solve their big data problems around cost optimization, service level agreement guarantees, and proactive monitoring and automated remediation so that they spend less time firefighting issues. From our view, recognition from Gartner as a Cool Vendor is very exciting, validates our work, and underscores the momentum we have as we reimagine big data and change the way our customers transform to being data-driven and insight-led.”
A complimentary copy of the “Cool Vendors in Performance Analysis; Analytics and Containers” (Padraig Byrne, Vivek Bhalla, et al., 12 September 2018) report can be downloaded here.
@Gartner_inc named @unraveldata a Cool Vendor in performance analysis, analytics and containers https://ctt.ac/oesBL+ #BigData #APM #DataOps
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Unravel Data
Unravel Data provides the only Application Performance Management (APM) solution for Big Data. Unravel doesn’t just monitor and unify system-level data, but also tracks, correlates, and interprets performance data across the full-stack in-order to optimize, troubleshoot, and analyze from a single pane. Customers include leading Big Data practitioners such as Kaiser Permanente, Leidos, Autodesk and YP.com. Unravel Data was founded by Kunal Agarwal and Dr. Shivnath Babu when they experienced the frustration of manually troubleshooting performance problems in Big Data stacks firsthand. Unravel’s founding team includes Big Data experts from companies such as Cloudera, Oracle, and Microsoft. Unravel Data has raised a total of $23 million of funding from Menlo Ventures, GGV Capital, M12, Data Elite Ventures and Jyoti Bansal.
The name Unravel Data is a trademark of Unravel Data™. Other trade names used in this document are the properties of their respective owners.
Jordan Tewell, 10Fold
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 10.12.2018 15:00 | Pressemelding
Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international center of excellence in neuroscience with its mission to improve lives through integrated clinical service, research and education, announced today that they have obtained animal proof of concept for CERESPIR’s clinical stage compound itanapraced in Parkinson’s disease models. Specifically, itanapraced, which was previously tested with positive results in patients with mild cognitive impairment (MCI), was shown to block the expression of LRRK2 and, additionally, prevent neurotoxicity resulting in the preservati
DSM Sinochem Pharmaceuticals announces its new name - Centrient Pharmaceuticals10.12.2018 13:29 | Pressemelding
The name, resulting from a change in ownership, reflects its role at the centre of modern healthcare ROTTERDAM, Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Effective December 10, 2018 Centrient Pharmaceuticals is the new name for DSM Sinochem Pharmaceuticals, the leading manufacturer of beta-lactam antibiotics and a provider of next-generation statins and anti-fungals . The new name has been chosen to reflect the company’s key contribution to modern healthcare, and marks the next phase in its strategic evolution following a change of ownership to Bain Capital Private Equity. CEO Karl Rotthier states: “Our bold and creative new name and logo showcase our company as one which prides itself on being at the centre of modern healthcare, through our life-saving active pharmaceutical ingredients and finished dosage forms. We’re building on a rich history that began 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, then Gist Brocades and more recently DSM Sinochem Pharmaceutica
General Electric Company: Dividend Declaration10.12.2018 08:00 | Pressemelding
FAIRFIELD, Conn., Dec. 10, 2018 (GLOBE NEWSWIRE) -- GE Board of Directors Authorizes Regular Quarterly Dividend The Board of Directors of GE (NYSE: GE) today declared a $0.01 per share dividend on the outstanding common stock of the Company. The dividend is payable January 25, 2019 to shareowners of record at the close of business on December 20, 2018. The ex- dividend date is December 19, 2018. About GE GE (NYSE:GE) drives the world forward by tackling its biggest challenges. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. For more than 125 years, GE has invented the future of industry, and today it leads new paradigms in additive manufacturing, materials science, and data analytics. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GE's mission and deliver for our customers. www.ge.com GE's Investor Relations website at www.ge.com/investor and our c
Brookfield Completes Acquisition of Forest City Realty Trust7.12.2018 19:24 | Pressemelding
NEW YORK and CLEVELAND, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Brookfield Asset Management Inc. (“Brookfield”) (NYSE: BAM) (TSX: BAM.A) (Euronext: BAMA) and Forest City Realty Trust, Inc. (“Forest City”) (NYSE: FCEA) today announced the completion of the acquisition of Forest City by a Brookfield real estate investment fund. The transaction was approved at a special meeting of Forest City’s stockholders held on November 15, 2018. Forest City’s diversified real estate portfolio is comprised of a number of iconic assets across major gateway U.S. cities. The portfolio, which features many natural synergies with Brookfield’s existing real estate operating business, includes 6.3 million square feet of high-quality office space, 2.3 million square feet of premier life sciences assets, 2.2 million square feet of retail space and 18,500 multifamily units. In addition, the portfolio features five large-scale development projects in the New York Metro area, San Francisco and Washington, DC. In connec
Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China7.12.2018 15:00 | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell Select kit by the China Food and Drug Administration (CFDA). The T-Cell Select kit was designed as an immune cell separation reagent kit to simplify workflow, improve throughput, and reduce hands-on time and labor costs in performing the T-SPOT®.TB test. With the T-Cell Select kit, blood samples collected in a single standard blood tube can be stored for up to 54 hours at room temperature before use, further extending the company’s unrivaled simplicity and logistics advantages for customers. For additional information, please visit: http://www.oxfordimmunotec.com/international/products-services/t-cell-select/. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for im
Colliers International Announces Leadership Change6.12.2018 22:05 | Pressemelding
Dylan Taylor tapped to lead Colliers Real Estate Services TORONTO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (NASDAQ and TSX: CIGI), a global leader in commercial real estate services and investment management, announced today that effective January 1, 2019, Dylan Taylor will become CEO of Colliers Real Estate Services focusing exclusively on the growth, operational effectiveness and client service opportunities in the Company’s rapidly growing real estate services segment. Jay Hennick, Global Chairman and CEO will continue to be responsible for overall strategy and execution across all the Company’s businesses including its recently established platform in investment management. “Dylan Taylor’s appointment to CEO of Colliers Real Estate Services recognizes his success in building our operations over the last nine years. He will continue to be the driving force behind our growth in real estate services globally and perhaps most importantly, delivering exceptio
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom